180 Followers on Owler
OverviewCompetitorsAcquisitionsFundingNews & Insights

JW Therapeutics Funding History

Since JW Therapeutics was founded in 2016, it has participated in 3 rounds of funding. In total JW Therapeutics has raised $490.0M. JW Therapeutics' last funding round was on Nov 2020 for a total of $300.0M.

JW Therapeutics Funding Rounds

ROUND

FUNDING DATE

AMOUNT

NUMBER OF INVESTORS

INVESTORS

IPO
Nov 2020
$300M
1
Series B
Jun 2020
$100M
8
Mirae Asset,  Oriza Holdings,  Loyal Valley Capital,  Temasek,  Sequoia Capital China,  ARCH Venture Partners,  Juno Therapeutics,  WuXi AppTec
Series A
Mar 2018
$90M
4
Temasek,  Sequoia,  WuXi AppTec,  Juno Therapeutics

Total Funding: $490M

JW Therapeutics Investors

Unlock 6 more investors →

INVESTOR

ROUND

FUNDING DATE

Mirae Asset
Series B
Jun 2020
Oriza Holdings
Series B
Jun 2020
Loyal Valley Capital
Series B
Jun 2020
Temasek
Series B, Series A
Jun 2020, Mar 2018
Sequoia Capital China
Series B
Jun 2020

Total Investors: 9

JW Therapeutics has 9 investors, including Mirae Asset, Oriza Holdings and Loyal Valley Capital. The latest investment occurred in Nov 2020.